Purpose of Review Allergic contact dermatitis (ACD) is a common condition and may entail negative impacts on people’s quality of life along with a substantial economic burden. Appropriately managing it through patient education, allergen avoidance, and symptom- atic treatment is crucial for its resolution. Our review aims to establish a practical approach to ACD management, based on a comprehensive discussion of available therapeutic options for ACD, a review of the latest findings in this field, and personal insights from our clinical practice experience. Recent Findings Topical treatments constitute the first-line therapy for ACD. Randomized clinical trials have shown topical corticosteroids to improve clinical and nonclinical outcomes, while tacrolimus has proven effective and safe. Evidence is lacking for oral corticosteroids in ACD sufferers, so recommendations for its use are primarily based on results obtained in dermatitis of other etiologies. In contrast, some studies have assessed azathioprine and phototherapy for ACD. Summary Patient education and allergen avoidance are paramount for managing ACD. However, individualized symptomatic treatment is warranted in several clinical situations. Although these treatments are widely used in clinical practice, few studies support their use for ACD. Further research is needed. Introduction Allergic contact dermatitis (ACD) is a delayed hypersen-
Current Treatment Options in Allergy – Springer Journals
Published: Jan 25, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera